OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Network meta‐analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method
Ulrich Mrowietz, Richard B. Warren, C. Leonardi, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 5, pp. 1161-1175
Open Access | Times Cited: 19

Showing 19 citing articles:

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2022) Vol. 2022, Iss. 8
Open Access | Times Cited: 106

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, Robin Guelimi, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 89

A novel hyaluronic acid-based dissolving microneedle patch loaded with ginsenoside Rg3 liposome for effectively alleviate psoriasis
Chi Huang, Kaijun Gou, Yue Xuan, et al.
Materials & Design (2022) Vol. 224, pp. 111363-111363
Open Access | Times Cited: 45

Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)
Andreas Pinter, L. Puig, Knut Schäkel, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 11, pp. 2087-2100
Open Access | Times Cited: 27

Comparing Meta-Analyses with ChatGPT in the Evaluation of the Effectiveness and Tolerance of Systemic Therapies in Moderate-to-Severe Plaque Psoriasis
Xuân‐Lan Lam Hoai, Thierry Simonart
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5410-5410
Open Access | Times Cited: 13

Overlapping network meta‐analyses on psoriasis systemic treatments, an overview: quantity does not make quality
Robin Guelimi, Sivem Afach, Jean-Philippe Régnaux, et al.
British Journal of Dermatology (2021) Vol. 187, Iss. 1, pp. 29-41
Open Access | Times Cited: 15

IL‐21 promoting angiogenesis contributes to the development of psoriasis
Dan Han, Fei Li, Yan Zhao, et al.
The FASEB Journal (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 4

Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Kristina Callis Duffin, Luis Daniel Mazzuoccolo, M.J. Cura, et al.
The Journal of Rheumatology (2022) Vol. 50, Iss. 1, pp. 131-143
Open Access | Times Cited: 7

Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics
Francesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology (2022) Vol. 157, Iss. 6
Closed Access | Times Cited: 6

Applicability of the Geographic Tongue Area and Severity Index among Healthcare Professionals: A Cross-Sectional Clinical Validation of a Newly Developed Geographic Tongue Scoring System
Bruna Lavinas Sayed Picciani, Lílian Rocha Santos, Thaylla Núñez Amin, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 23, pp. 5493-5493
Open Access | Times Cited: 5

Expert consensus on the treat-to-target strategy for psoriasis with biological agents in China
Aijun Chen, Daxing Cai, Xiang Chen, et al.
International Journal of Dermatology and Venereology (2023) Vol. 7, Iss. 2, pp. 61-69
Open Access | Times Cited: 1

Comparison of adalimumab and secukinumab with respect to short-term efficacy and recurrence in moderate-tosevere psoriasis patients
Bing Wang, Lei You, Xi’ang Yue
Tropical Journal of Pharmaceutical Research (2022) Vol. 21, Iss. 6, pp. 1323-1328
Open Access | Times Cited: 1

Biologics update: IL‐23 inhibitors
Julie Hong, Edward Hadeler, Megan Mosca, et al.
Dermatological Reviews (2021) Vol. 2, Iss. 5, pp. 276-281
Closed Access

Page 1

Scroll to top